Lenox Wealth Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$8K Hold
159
﹤0.01% 524
2021
Q4
$9K Hold
159
﹤0.01% 532
2021
Q3
$9K Hold
159
﹤0.01% 490
2021
Q2
$10K Buy
+159
New +$10.5K ﹤0.01% 480
2020
Q1
Sell
-5
Closed 952
2019
Q4
$0 Buy
+5
New +$279 ﹤0.01% 833
2018
Q3
Sell
-117
Closed -$5K 528
2018
Q2
$5K Sell
117
-37
-24% -$1.74K ﹤0.01% 460
2018
Q1
$8K Buy
154
+117
+316% +$6.89K ﹤0.01% 386
2017
Q4
$2K Buy
+37
New +$2.35K ﹤0.01% 354

Other funds holding XRAY

Lenox Wealth Advisors's XRAY Position: Q1 2022 in Review

Lenox Wealth Advisors held its Dentsply Sirona (XRAY) position steady in Q1 2022 at 159 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Lenox Wealth Advisors first reported a position in XRAY in Q4 2017 and has held it in 8 quarters since. The position peaked at $10K in Q2 2021. 537 funds tracked by Wall St. Rank hold XRAY as of Q1 2022.

  • Lenox Wealth Advisors held 159 shares of Dentsply Sirona worth $8K as of Q1 2022.
  • Lenox Wealth Advisors left its Dentsply Sirona share count unchanged in Q1 2022.
  • Dentsply Sirona made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #524 holding.
  • Lenox Wealth Advisors first reported a position in Dentsply Sirona in Q4 2017 and has held it in 8 quarters since.
  • Lenox Wealth Advisors's Dentsply Sirona position peaked at $10K in Q2 2021.
  • 537 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.